GuruTrack
RLAY

RLAY

RELAY THERAPEUTICS INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary
RELAY THERAPEUTICS INC (RLAY) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$82.95M; the largest are Baker Bros. Advisors, Izzy Englander, Ken Griffin. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 3 added, 1 trimmed, 1 closed. 3 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Heating up
Common-stock holders51 also report options
Congress trades3
Price$18.36vs quarter-end-1.87%
Sectors0
This quarter's moves
New1
Added3
Trimmed / sold2
Top holderBaker Bros. Advisors

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Value $10.50M— of portfolio561,4002026 Q2
Value $4.71M— of portfolio252,0002026 Q2

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.